Asahi Kasei Pharma America (AKP America)
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
200 5th Ave Fl 6, Waltham, Massachusetts...Phone Number
(781) 419-1919Website
www.asahikasei-pharma.co.jpRevenue
$11.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Asahi Kasei Pharma America (AKP America)
Asahi Kasei Pharma America (AKP America) is a biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients throughout the world. The company is a wholly-owned subsidiary of Asahi Kasei Pharma Corp.Explore more
Asahi Kasei Pharma America (AKP America) Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Asahi Kasei Pharma America (AKP America) your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Asahi Kasei Pharma America (AKP America) launches new products
Congratulate Masked Content for being promoted to Masked Content at Asahi Kasei Pharma America (AKP America)
Click to see if Asahi Kasei Pharma America (AKP America) had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Asahi Kasei Pharma America (AKP America) has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Asahi Kasei Pharma America (AKP America) recently announced quarterly report
Check out if Asahi Kasei Pharma America (AKP America) is spiking on competitors!
Check if Asahi Kasei Pharma America (AKP America) has recently received funding, and reach out quickly before it becomes old news!
Asahi Kasei Pharma America (AKP America), which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Asahi Kasei Pharma America (AKP America) is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Asahi Kasei Pharma America (AKP America) is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Asahi Kasei Pharma America (AKP America).
Asahi Kasei Pharma America (AKP America) financials insights
Gather financial insights about Asahi Kasei Pharma America (AKP America), including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Series A
$39M
2010
Series B
$22M
Series C
$3M
Asahi Kasei Pharma America (AKP America) Tech Stack
A closer look at the technologies used by Asahi Kasei Pharma America (AKP America)
Asahi Kasei Pharma America (AKP America) News & Media
AGC Biologics Partners with Asahi Kasei Pharma Corporation on Clinical Antibody Project
SEATTLE--(BUSINESS WIRE)--AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new agreement with Asahi Kasei Pharma Corporation to produce clinical drug substance for antibody-based therapies at AGC Biologics’ Seattle manufacturing site. Under the agreement, AGC Biologics will leverage its monoclonal antibody development and manufacturing experience to perform process transfer, process optimization, and clinical manufacVectivBio and Asahi Kasei Pharma Announce the Start of a Phase 1 Study of Apraglutide in Japan
Single-dose study to assess pharmacokinetics, pharmacological activity, safety and tolerability in healthy Japanese men and women Single-dose study to assess pharmacokinetics, pharmacological activity, safety and tolerability in healthy Japanese men and womenArisGlobal LifeSphere® MultiVigilance is selected by Asahi Kasei Pharma
MIAMI and TOKYO, Oct. 6, 2021 /PRNewswire/ -- Asahi Kasei Pharma Corp. has selected LifeSphere® MultiVigilance as a new safety database with the purpose of building a system that supports efficiency, regulatory compliance, and global collaboration over the long term. In addition, Asahi Kasei Pharma will adopt ArisGlobal's rapid migration methodology, which has been successfully embraced by many of the world's leading life sciences companies when transitioning from their legacy safety systems. "WAgNovos Healthcare and Asahi Kasei Pharma Enter Into an Exclusive Option Agreement for Japan
NEW YORK--(BUSINESS WIRE)--AgNovos Healthcare, LLC (“AgNovos”) and Asahi Kasei Pharma Corporation (“Asahi Kasei Pharma”) announced today that the companies have entered into an exclusive option agreement for the commercialization of AgNovos’ AGN1 LOEP Hip Kit in Japan. The kit is used to perform a minimally invasive procedure to treat osteoporotic bone loss in the hip. AgNovos will receive up to $19.5 million of non-dilutive funding. If the AGN1 LOEP Hip Kit is successfully developed and
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Asahi Kasei Pharma America (AKP America)
Sign Up For FreeTo access detailed company insights
Asahi Kasei Pharma America (AKP America) is a biopharmaceutical company dedicated to bringing best-in-class critical care therapeutics to patients throughout the world. The company is a wholly-owned subsidiary of Asahi Kasei Pharma Corp.... Read More
